日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

FDA Approval Summary: Niraparib plus Abiraterone Acetate Fixed-Dose Combination for BRCA-Mutated Metastatic Castration-Resistant Prostate Cancer

FDA批准摘要：尼拉帕尼联合醋酸阿比特龙固定剂量组合用于治疗BRCA突变转移性去势抵抗性前列腺癌

期刊:Clinical Cancer Research
影响因子:10.2
doi:10.1158/1078-0432.CCR-25-0883
Maguire, William F; Chi, Dow-Chung; Agrawal, Sundeep; Joeng, Hee-Koung; Kim-McOlash, Sarah; Manheng, Wimolnut; Bulatao, Ilynn; Sanchez-Solana, Beatriz; Pathak, Anand; Lee, Alice; Han, Yu; Ricks, Tiffany K; Hamed, Salaheldin S; Fiero, Mallorie H; Pierce, William F; Kalavar, Shyam; Ghosh, Soma; Leighton, John K; Tang, Shenghui; Amiri-Kordestani, Laleh; Kluetz, Paul G; Suzman, Daniel L
肿瘤
前列腺癌
肿瘤免疫
发表日期：2025
文献求助 收藏

FDA Approval Summary: Nogapendekin Alfa Inbakicept-pmln with BCG for BCG-Unresponsive Carcinoma In Situ

FDA批准摘要：诺加潘地金α（Nogapendekin Alfa）联合卡介苗（BCG）治疗对卡介苗无反应的原位癌

期刊:Clinical Cancer Research
影响因子:10.2
doi:10.1158/1078-0432.CCR-25-1231
Heiss, Brian L; Chang, Elaine; Joeng, Hee-Koung; Fiero, Mallorie H; Wang, Lingshan; Hamed, Salaheldin S; Chiu, Haw-Jyh; Ricks, Tiffany K; Koh, Eun Hee; Dellibovi-Ragheb, Teegan A; Wang, Min; Lee, Christal; Pierce, William F; Leighton, John K; Rahman, Nam Atiqur; Tang, Shenghui; Pazdur, Richard; Amiri-Kordestani, Laleh; Kluetz, Paul G; Suzman, Daniel L
肿瘤
肿瘤免疫
发表日期：2025
文献求助 收藏

FDA Approval Summary: Nadofaragene Firadenovec-vncg for Bacillus Calmette-Guérin-Unresponsive Non-Muscle-Invasive Bladder Cancer

FDA批准摘要：Nadofaragene Firadenovec-vncg用于治疗卡介苗无效的非肌层浸润性膀胱癌

期刊:Clinical Cancer Research
影响因子:10.2
doi:10.1158/1078-0432.CCR-24-2812
Colbert, Laronna; Jia, Yuxia; Sharma, Anurag; Hu, Jiang; Xu, Zhenzhen; Suzman, Daniel L; Das, Asha; Bross, Peter; Kluetz, Paul G; Fashoyin-Aje, Lola A
肿瘤
肿瘤免疫
膀胱癌
发表日期：2025
文献求助 收藏

The Food and Drug Administration pooled analysis of overall survival according to depth of response in frontline advanced immune-oncology renal cell carcinoma trials

美国食品药品监督管理局对一线晚期免疫肿瘤治疗肾细胞癌的试验中，根据反应深度对总生存期进行了汇总分析。

期刊:JNCI Cancer Spectrum
影响因子:4.1
doi:10.1093/jncics/pkaf069
Chang, Elaine; Gittleman, Haley; Song, Chi; Bloomquist, Erik; Fernandes, Laura; Weinstock, Chana; Agrawal, Sundeep; Gormley, Nicole; Tang, Shenghui; Suzman, Daniel L; Amiri-Kordestani, Laleh; Pazdur, Richard; Kluetz, Paul G; McDermott, David F; Regan, Meredith M; Rini, Brian I
肿瘤
肿瘤免疫
肾癌
细胞生物学
免疫/内分泌
发表日期：2025
文献求助 收藏

Trends of upgrading and upstaging of grade group 1 prostate cancer at radical prostatectomy: NCDB and SEER results from 2010 to 2021

根治性前列腺切除术中1级前列腺癌升级和分期上升的趋势：2010年至2021年NCDB和SEER结果

期刊:Current Urology
影响因子:1.3
doi:10.1097/CU9.0000000000000296
Suzman, Evan; Wang, Shu; Hu, Jim C
肿瘤
前列腺癌
肿瘤免疫
发表日期：2025
文献求助 收藏

Efficacy of Poly(ADP-ribose) Polymerase Inhibitors by Individual Genes in Homologous Recombination Repair Gene-Mutated Metastatic Castration-Resistant Prostate Cancer: A US Food and Drug Administration Pooled Analysis

聚（ADP-核糖）聚合酶抑制剂对同源重组修复基因突变型转移性去势抵抗性前列腺癌中单个基因的疗效：美国食品药品监督管理局汇总分析

期刊:Journal of Clinical Oncology
影响因子:41.9
doi:10.1200/JCO.23.02105
Fallah, Jaleh; Xu, Jianjin; Weinstock, Chana; Gao, Xin; Heiss, Brian L; Maguire, William F; Chang, Elaine; Agrawal, Sundeep; Tang, Shenghui; Amiri-Kordestani, Laleh; Pazdur, Richard; Kluetz, Paul G; Suzman, Daniel L
肿瘤
前列腺癌
肿瘤免疫
发表日期：2024
文献求助 收藏

US Food and Drug Administration Approval Summary: Talazoparib in Combination With Enzalutamide for Treatment of Patients With Homologous Recombination Repair Gene-Mutated Metastatic Castration-Resistant Prostate Cancer

美国食品药品监督管理局批准摘要：他拉唑帕尼联合恩扎卢胺治疗同源重组修复基因突变转移性去势抵抗性前列腺癌患者

期刊:Journal of Clinical Oncology
影响因子:41.9
doi:10.1200/JCO.23.02182
Heiss, Brian L; Chang, Elaine; Gao, Xin; Truong, Tien; Brave, Michael H; Bloomquist, Erik; Shah, Ankit; Hamed, Salaheldin; Kraft, Jeffrey; Chiu, Haw-Jyh; Ricks, Tiffany K; Tilley, Amy; Pierce, William F; Tang, Liuya; Abukhdeir, Abdelrahmman; Kalavar, Shyam; Philip, Reena; Tang, Shenghui; Pazdur, Richard; Amiri-Kordestani, Laleh; Kluetz, Paul G; Suzman, Daniel L
肿瘤
前列腺癌
肿瘤免疫
发表日期：2024
文献求助 收藏

FDA Approval Summary: Enfortumab Vedotin plus Pembrolizumab for Cisplatin-Ineligible Locally Advanced or Metastatic Urothelial Carcinoma

FDA批准摘要：恩福妥单抗联合帕博利珠单抗用于不适合顺铂治疗的局部晚期或转移性尿路上皮癌

期刊:Clinical Cancer Research
影响因子:10.2
doi:10.1158/1078-0432.CCR-23-3738
Maguire, William F; Lee, Daniel; Weinstock, Chana; Gao, Xin; Bulik, Catharine C; Agrawal, Sundeep; Chang, Elaine; Hamed, Salaheldin S; Bloomquist, Erik W; Tang, Shenghui; Pazdur, Richard; Kluetz, Paul G; Amiri-Kordestani, Laleh; Suzman, Daniel L
肿瘤
肿瘤免疫
发表日期：2024
文献求助 收藏

FDA Approval Summary: Enfortumab Vedotin plus Pembrolizumab for Locally Advanced or Metastatic Urothelial Carcinoma

FDA批准摘要：恩福妥单抗联合帕博利珠单抗治疗局部晚期或转移性尿路上皮癌

期刊:Clinical Cancer Research
影响因子:10.2
doi:10.1158/1078-0432.CCR-24-1393
Brave, Michael H; Maguire, William F; Weinstock, Chana; Zhang, Hui; Gao, Xin; Li, Fang; Yu, Jingyu; Fu, Wentao; Zhao, Hong; Pierce, William F; Chang, Elaine; Dinin, Jeannette; Fiero, Mallorie H; Rahman, Nam Atiqur; Tang, Shenghui; Pazdur, Richard; Kluetz, Paul G; Amiri-Kordestani, Laleh; Suzman, Daniel L
肿瘤
肿瘤免疫
发表日期：2024
文献求助 收藏

FDA Approval Summary: Belzutifan for Patients with Advanced Renal Cell Carcinoma

FDA批准摘要：Belzutifan用于治疗晚期肾细胞癌患者

期刊:Clinical Cancer Research
影响因子:10.2
doi:10.1158/1078-0432.CCR-24-1199
Fallah, Jaleh; Heiss, Brian L; Joeng, Hee-Koung; Weinstock, Chana; Gao, Xin; Pierce, William F; Chukwurah, Benjamin; Bhatnagar, Vishal; Fiero, Mallorie H; Amiri-Kordestani, Laleh; Pazdur, Richard; Kluetz, Paul G; Suzman, Daniel L
肿瘤
肾癌
肿瘤免疫
细胞生物学
发表日期：2024
文献求助 收藏